-+ 0.00%
-+ 0.00%
-+ 0.00%

bioAffinity Technologies Reports Q1 CyPath Lung Diagnostic Unit Sales Up 146% YoY

Benzinga·04/01/2026 12:08:30
Listen to the news

Noninvasive diagnostic continues to gain traction in the current and expanding U.S. addressable market of $3.58 billion for pulmonary nodule management and surveillance of lung cancer survivors

Flow cytometry+AI technology has potential to improve lung cancer risk assessment and nodule management